Latest News

Page 10 of 29« First...89101112...20...Last »

December 23, 2015

Glaucoma Awareness Can Help Save Your Vision

Posted in: Eye Conditions, Latest News

Important Information from the National Eye Institute Glaucoma is a major cause of vision loss in the U.S. While it currently affects about 3 million Americans, estimates show 6.3 million could have glaucoma by 2050. With Glaucoma Awareness Month in January, it’s a good time to think about scheduling a comprehensive dilated eye exam, especially
read more »

December 11, 2015

Triple Therapy with Zeaxanthin Lessens Burden of Treatment for Wet AMD

Posted in: Health and Nutrition, Latest News, Research and Developments

As far back as 2007, triple therapy for wet (neovascular) age-related macular degeneration (AMD) was shown to be superior to mono therapy (intraocular injection of a single anti-VEGF drug).* And now, a study described in a recent online publication of the peer-reviewed monthly, International Journal of Retina and Vitreous, found that triple therapy supplemented with
read more »

December 10, 2015

Delayed Dark Adaptation Predicts Onset of Dry AMD

Posted in: Latest News, Research and Developments

A recent study* at the University of Alabama has found that measurement of the time it takes older adults’ eyes to adapt to the dark can predict onset of dry age-related macular degeneration (dAMD). Using a computerized dark adaptometer, 325 persons with healthy eyes were each subjected to a flash of light in one eye,
read more »

November 16, 2015

X-82 Oral Medication May Reduce Number of Intravitreal Injections for Wet AMD

Posted in: Latest News, Research and Developments

No cure yet exists for wet AMD, but three FDA-approved therapies are slowing the progress of wet AMD and reducing the amount of vision loss. These treatments are ranibizumab (Lucentis), aflibercept (Eylea), and off-label bevacizumab (Avastin). These medications are highly successful, but they must be injected directly into the eye, and the treatment often needs
read more »

November 16, 2015

Iluvien Similar to Anti-VEGF Drugs as Treatment for Diabetic Retinopathy

Posted in: Latest News, Research and Developments, Therapies, Treatments, and Procedures

(Updated 12/5/2017) On February 16, Charles C. Wykoff, MD, PhD, announced to the American Academy of Ophthalmology annual meeting that Iluviuan (fluocinolone acetonide) treatment, after 1.3 injections over 3 years in the FAME trials, “significantly reduced progression to prolific diabetic retinopathy from 31% to 17%, a similar reduction as observed with monthly anti-VEGF treatments.” Iluvian
read more »

November 16, 2015

Lucentis effective for proliferative diabetic retinopathy

Posted in: Latest News, Therapies, Treatments, and Procedures

NIH-funded clinical trial marks first major advance in therapy in 40 years A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy. The trial, conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) compared Lucentis with a type of laser
read more »

November 7, 2015

Medicare Covers Annual Eye Exams for Diabetics

Posted in: Latest News

November is American Diabetes Month. To prevent diabetes-related vision loss, the American Academy of Ophthalmology recommends people with diabetes get a dilated eye exam each year.   One in four Americans age 65 or older has diabetes, putting them at increased risk for vision loss and blindness. Fortunately, diabetes-related vision loss is largely preventable with
read more »

October 31, 2015

LowViz Guide Completes Successful Pilot Program

Posted in: Latest News

New indoor navigation app available free for low vision conventions. LowViz Guide, an indoor navigation app for the visually impaired, was tested this past summer by Macular Degeneration Support (MD Support) at six national and state conventions around the U.S. The purpose of the ambitious pilot project was to test the operation of, and public response
read more »

October 27, 2015

RXI-109 May Reduce Retinal Scarring

Posted in: Latest News, Research and Developments

New drug silences connective tissue growth factor (CTGF), which plays a key role in tissue regeneration and repair. by Dan Roberts One of the most serious causes of vision loss is development of scar tissue on, in, or under the retina. People can develop retinal scarring from severe myopia, ocular histoplasmosis syndrome, and wet age-related
read more »

September 28, 2015

Wet AMD and DME Patients Sought For New Study

Posted in: Latest News

PIVOT Study: Patient-centric Innovative Vision Home Testing Patients are being sought to participate in a unique study to gauge the feasibility of a home-monitoring system. The PIVOT study is a clinical study to determine if patients with diabetic macular edema (DME) or wet age-related macular degeneration (wet AMD) can use a mobile medical application (mVT™) on a smart phone (Apple iPhone®) or
read more »

Page 10 of 29« First...89101112...20...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann